Boostrix (difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis (antigenen) suspensie voor injectie (i.m.) (volw. en kind)) · CNK 1734094

Product information

Boostrix
1 dose
difterie-anatoxine + tetanus-anatoxine + Bordetella pertussis (antigenen) suspensie voor injectie (i.m.) (volw. en kind)
1734094
3.5 / 10
Locked

Product properties

x
J07AJ52
GlaxoSmithKline Biologicals
Suspension for injection
BE220963
05050459000750, 05050459002792, 05050459006820, 05400571000457
M1
Public
220963-01

Pharmacist Assessment

Structurally fluctuating availability

This product has chronically fluctuating availability (current 3.5/10, historical 🔒/10). Be prepared for possible supply issues and consider keeping an alternative in stock.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 8 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Available Active
Published 31/01/2024

Composition

6 ingredients

Substance Type Strength CAS
Active ingredient
8 ug
Active ingredient
20 [iU]
Active ingredient
2 [iU]
Active ingredient
2.5 ug
Active ingredient
8 ug
Excipient
4.5 mg/{dose}

Additional information

Availability statistics

Available
0 days
2
0